Skip to main content
logo
IRADIMED CORPORATION (IRMD)
NASDAQ: IRMD · Real-Time Price · USD
87.07
+0.07 (0.08%)
At close: Aug 28, 2026, 4:00 PM EDT
86.61
-0.46 (-0.53%)
Pre-market: Aug 31, 2026, 5:59 AM EDT

IRADIMED CORPORATION Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
23.0622.4819.2317.1912.839.33
Depreciation & Amortization
1.631.170.820.770.671.41
Loss (Gain) From Sale of Assets
0.040.0400.01-00.01
Loss (Gain) From Sale of Investments
-----0.01-0.02
Stock-Based Compensation
2.852.922.522.191.391.46
Provision & Write-off of Bad Debts
-0.07-0.08-0.10.210.10.01
Other Operating Activities
2.292.77-0.61-0.990.110.64
Change in Accounts Receivable
-2.2-3.031.760.84-8.24-0.58
Change in Inventory
-1.56-1.383.13-7.47-1.31-0.39
Change in Accounts Payable
-0.05-0.08-0.86-0.221.120.03
Change in Unearned Revenue
0.941.6-0.110.620.530.05
Change in Income Taxes
-0.46-0.76-0.790.253.05-0.83
Change in Other Net Operating Assets
0.68-0.70.620.06-0.210.14
Operating Cash Flow
27.1424.9525.6213.4710.0411.26
Operating Cash Flow Growth
-0.01%-2.64%90.30%34.08%-10.80%93.52%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-2.02-7.77-8.01-7.44-0.82-0.48
Sale (Purchase) of Intangibles
-0.57-0.66-0.81-0.57-1.05-0.26
Investment in Securities
----0.51.39
Investing Cash Flow
-2.59-8.42-8.82-8.01-1.370.65

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
--0.030.180.150.62
Repurchase of Common Stock
-2.63-2.56-0.69-0.61-0.29-0.6
Common Dividends Paid
-15.83-15.04-13.68-13.22-12.56-
Financing Cash Flow
-18.46-17.6-14.34-13.66-12.710.02

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Miscellaneous Cash Flow Adjustments
0-0---
Net Cash Flow
6.08-1.082.47-8.2-4.0411.93

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
25.1217.1817.626.029.2210.78
Free Cash Flow Growth
76.79%-2.48%192.46%-34.66%-14.44%100.50%
Free Cash Flow Margin
29.09%20.50%24.06%9.19%17.30%25.77%
Free Cash Flow Per Share
1.951.341.380.470.730.86
Levered Free Cash Flow
16.26.644.18.45.898.16
Unlevered Free Cash Flow
16.26.644.18.45.898.16

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
4.963.926.515.351.710.97
Change in Working Capital
-2.65-4.353.75-5.91-5.06-1.58
SEC Filings: 10-K · 10-Q